Skip to main content

Date last updated: 06/15/2021

 

General comments:  We provide these summary data in the spirit of transparency and open data sharing.  Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.

 

Total number of cases reported: 6,262

 

Report a Case

Cases reported by country*

countryN
United States2212
United Arab Emirates20
Afghanistan1
Argentina88
Austria124
Australia12
Belgium176
Bulgaria34
Bahrain1
Saint Barthélemy1
Bolivia, Plurinational State of1
Brazil140
Canada176
Switzerland43
Chile32
China1
Colombia3
Costa Rica4
Cyprus4
Czech Republic60
Germany217
Denmark1
Dominican Republic15
Ecuador4
Egypt2
Spain446
Finland7
France130
United Kingdom232
Greece70
Croatia25
Hungary6
Ireland83
Israel45
India37
Iran, Islamic Republic of58
Italy188
Japan58
Korea, Republic of3
Kuwait23
Kazakhstan1
Lebanon3
Luxembourg1
Latvia4
Morocco8
Moldova, Republic of14
Mexico18
Malaysia3
Netherlands335
Norway17
Nepal1
New Zealand1
Peru10
Philippines6
Poland53
Portugal127
Paraguay1
Qatar2
Romania16
Serbia15
Russian Federation475
Saudi Arabia14
Sweden2
Slovenia16
Slovakia103
Tunisia2
Turkey121
Ukraine1
Uruguay8
Venezuela, Bolivarian Republic of4
South Africa17
Missing80

* Countries not included in this table have not reported any cases to SECURE-IBD

 

Cases reported by state (U.S. only)*

stateN
ALABAMA24
ARIZONA19
ARKANSAS10
CALIFORNIA123
COLORADO16
CONNECTICUT31
DELAWARE4
DISTRICT OF COLUMBIA10
FLORIDA88
GEORGIA56
IDAHO9
ILLINOIS197
INDIANA14
IOWA23
KANSAS15
KENTUCKY14
LOUISIANA43
MAINE2
MARYLAND39
MASSACHUSETTS66
MICHIGAN42
MINNESOTA78
MISSISSIPPI29
MISSOURI46
MONTANA12
NEBRASKA47
NEVADA6
NEW HAMPSHIRE3
NEW JERSEY84
NEW MEXICO1
NEW YORK296
NORTH CAROLINA73
NORTH DAKOTA3
OHIO144
OKLAHOMA8
OREGON8
PENNSYLVANIA97
RHODE ISLAND24
SOUTH CAROLINA18
SOUTH DAKOTA3
TENNESSEE62
TEXAS88
UTAH19
VERMONT3
VIRGINIA44
WASHINGTON36
WEST VIRGINIA1
WISCONSIN62
GUAM2
PUERTO RICO2
NA66
stateN
ALABAMA24
ARIZONA19
ARKANSAS10
CALIFORNIA124
COLORADO16
CONNECTICUT31
DELAWARE4
DISTRICT OF COLUMBIA10
FLORIDA88
GEORGIA56
IDAHO9
ILLINOIS197
INDIANA14
IOWA23
KANSAS15
KENTUCKY14
LOUISIANA43
MAINE2
MARYLAND39
MASSACHUSETTS66
MICHIGAN43
MINNESOTA78
MISSISSIPPI29
MISSOURI46
MONTANA12
NEBRASKA47
NEVADA6
NEW HAMPSHIRE3
NEW JERSEY84
NEW MEXICO1
NEW YORK296
NORTH CAROLINA73
NORTH DAKOTA3
OHIO144
OKLAHOMA8
OREGON8
PENNSYLVANIA97
RHODE ISLAND24
SOUTH CAROLINA18
SOUTH DAKOTA3
TENNESSEE62
TEXAS88
UTAH19
VERMONT3
VIRGINIA44
WASHINGTON36
WEST VIRGINIA1
WISCONSIN62
GUAM2
PUERTO RICO2
NA66

* States not included in this table have not reported any cases to SECURE-IBD

 

Cases and outcomes by patient characteristics

CharacteristicTotal NOutpatient only (n, %)Hospitalized (n, %)ICU (n, %)Ventilator (n, %)Death (n, %)ICU/Ventilator/Death (n, %)
Overall6,2625,23084%95415%1773%1372%1022%2474%
Age
0-9 years 413790%37%25%25%00%25%
10-19 years 65161795%274%41%10%00%41%
20-29 years 1,2911,17691%1018%40%10%10%50%
30-39 years 1,3071,15688%13010%161%81%40%171%
40-49 years 1,11895585%15414%242%182%40%272%
50-59 years 93773078%20121%404%374%131%546%
60-69 years 52433965%17333%5410%438%275%6312%
70-79 years 21911954%9543%2511%199%2311%3918%
>=80 years 1356649%6649%64%86%2921%3425%
Sex
Male 3,0022,43981%52918%943%752%702%1405%
Female 3,1602,70686%41313%803%592%321%1043%
Other 3267%00%00%00%00%00%
Disease type
Crohn’s disease 3,5793,08986%44813%742%592%441%1013%
Ulcerative Colitis/unspecified2,6422,10880%50119%1014%763%572%1445%
IBD Disease
Activity
Remission3,4552,97586%45713%883%752%501%1274%
Mild1,3521,15886%17913%282%212%191%433%
Moderate/Severe1,16087075%27424%514%333%272%656%
Unknown29522777%4415%103%83%62%124%
Smoking
Current smoker24620282%4418%62%21%52%94%
Non-smoker6,0165,02884%91015%1713%1352%972%2384%
Comorbidities
04,4663,99189%42810%511%391%100%631%
11,24996577%26021%494%353%282%645%
233119559%13240%3210%309%227%4815%
3+2167937%13462%4521%3315%4219%7233%
IBD medication
Sulfasalazine/mesalamine1,8631,44578%40021%784%674%513%1136%
Budesonide 17012875%4124%95%53%64%127%
Oral/parenteral steroids 39924962%14336%4010%277%267%5113%
6MP/azathioprine monotherapy53342179%10820%265%173%112%336%
Methotrexate monotherapy483471%1327%12%12%24%36%
Anti-TNF without 6MP/AZA/MTX 2,0371,84390%1749%221%161%100%291%
Anti-TNF + 6MP/AZA/MTX 62252484%8914%173%112%51%203%
Anti-integrin 68958785%9213%193%101%81%264%
IL 12/23 inhibitor 58452189%509%92%81%51%112%
JAK inhibitor 998889%1010%33%11%11%33%
Other IBD medication 20015477%4322%95%53%42%95%

*Medication categories are not mutually exclusive

 

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.